Nanocrystallization of the pharmaceutically active agent genipin by an emulsion solvent evaporation method

Journal of Nanomaterials

Volumn 2014, Issue , 2014, Pages

  Zu, Yuangang ^a   Yu, Xinyang ^a   Zhao, Xiuhua ^a   Wang, Weiguo ^a   Wang, Kunlun ^a  

^a NORTHEAST FORESTRY UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; DISSOLUTION; EMULSIFICATION; EVAPORATION; EXPERIMENTS; NANOCRYSTALLIZATION; SOLUBILITY; SOLVENTS;

EMULSION-SOLVENT EVAPORATION METHOD; EXPERIMENTAL PARAMETERS; HOMOGENIZATION PRESSURES; NANO-CRYSTALLIZATION PROCESS; OPTIMIZATION CONDITIONS; ORAL BIOAVAILABILITIES; PHARMACEUTICALLY ACTIVE AGENTS; SINGLE-FACTOR EXPERIMENTS;

NANOPARTICLES;

EID: 84904702543     PISSN: 16874110     EISSN: 16874129     Source Type: Journal    
DOI: 10.1155/2014/240950     Document Type: Article

References (38)

1. Muzzarelli R. A. A., Genipin-crosslinked chitosan hydrogels as biomedical and pharmaceutical aids. Carbohydrate Polymers 2009 77 1 1 9 10.1016/j.carbpol.2009.01.016 2-s2.0-64749115024
2. Liu B.-S., Huang T.-B., Nanocomposites of genipin-crosslinked chitosan/silver nanoparticles-structural reinforcement and antimicrobial properties. Macromolecular Bioscience 2008 8 10 932 941 10.1002/mabi.200800053 2-s2.0-60549106719
3. Moon S. H., Choi H. J., Lee S. J., Chung J. U., Kim J. H., Chung D. H., Park M. S., Cho I. K., Choi K. H., Genipin derivative having anti hepatitis B virus activity. Google Patents, 2000
4. Koo H.-J., Song Y. S., Kim H.-J., Lee Y., Hong S., Kim S., Kim B., Jin C., Lim C., Park E., Antiinflammatory effects of genipin, an active principle of gardenia. European Journal of Pharmacology 2004 495 2-3 201 208 10.1016/j.ejphar.2004.05.031 2-s2.0-3042788976 (Pubitemid 38891877)
5. Zhang C., Parton L. E., Ye C. P., Krauss S., Shen R., Lin C., Porco J. A. Jr., Lowell B. B., Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced β cell dysfunction in isolated pancreatic islets. Cell Metabolism 2006 3 6 417 427 10.1016/j.cmet.2006.04.010 2-s2.0-33744548069 (Pubitemid 43811776)
6. Yamamoto M., Miura N., Ohtake N., Amagaya S., Ishige A., Sasaki H., Komatsu Y., Fukuda K., Ito T., Terasawa K., Genipin, a metabolite derived from the herbal medicine Inchin-ko-to, and suppression of Fas-induced lethal liver apoptosis in mice. Gastroenterology 2000 118 2 380 389 10.1016/S0016-5085(00) 70220-4 2-s2.0-0033973569 (Pubitemid 30067511)
7. Yamazaki M., Chiba K., Genipin exhibits neurotrophic effects through a common signaling pathway in nitric oxide synthase-expressing cells. European Journal of Pharmacology 2008 581 3 255 261 10.1016/j.ejphar.2007.12.001 2-s2.0-38949217989
8. Tian J., Cui Y., Hu L., Gao S., Chi W., Dong T., Liu L., Antidepressant-like effect of genipin in mice. Neuroscience Letters 2010 479 3 236 239 10.1016/j.neulet.2010.05.069 2-s2.0-77954141711
9. Yao C., Liu B., Chang C., Hsu S., Chen Y., Preparation of networks of gelatin and genipin as degradable biomaterials. Materials Chemistry and Physics 2004 83 2-3 204 208 10.1016/j.matchemphys.2003.08.027 2-s2.0-0348170745
10. Wang Q. S., Xiang Y., Cui Y. L., Lin K. M., Zhang X. F., Dietary blue pigments derived from genipin, attenuate inflammation by inhibiting LPS-induced iNOS and COX-2 expression via the NF- B inactivation. PLoS ONE 2012 7 3 e34122 10.1371/journal.pone.0034122 2-s2.0-84859118071
11. Merisko-Liversidge E. M., Liversidge G. G., Drug nanoparticles: formulating poorly water-soluble compounds. Toxicologic Pathology 2008 36 1 43 48 10.1177/0192623307310946 2-s2.0-41949100244
12. Kunieda H., Shinoda K., Krafft points, critical micelle concentrations, surface tension, and solubilizing power of aqueous solutions of fluorinated surfactants. The Journal of Physical Chemistry 1976 80 22 2468 2470 10.1021/j100563a007 2-s2.0-0001560906
13. Leuner C., Dressman J., Improving drug solubility for oral delivery using solid dispersions. European Journal of Pharmaceutics and Biopharmaceutics 2000 50 1 47 60 10.1016/S0939-6411(00)00076-X 2-s2.0-0034601240 (Pubitemid 30326688)
14. Vasconcelos T., Sarmento B., Costa P., Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today 2007 12 23-24 1068 1075 10.1016/j.drudis.2007.09.005 2-s2.0-36549042006 (Pubitemid 350186132)
15. Shinde V., Amsa P., Tamizharasi S., Karthikeyan D., Sivakumar T., Kosalge A., Nanosuspensions: a promising drug delivery strategy. Research Journal of Pharmacy and Technology 2010 3 39 44
16. Mijatovic D., Eijkel J., van den Berg A., Technologies for nanofluidic systems: top-down vs. bottom-up-a review. Lab on a Chip-Miniaturisation for Chemistry and Biology 2005 5 5 492 500 10.1039/b416951d 2-s2.0-18744363890 (Pubitemid 40676814)
17. Debenedetti P. G., Tom J. W., Kwauk X., Yeo S.-D., Rapid expansion of supercritical solutions (RESS): fundamentals and applications. Fluid Phase Equilibria 1993 82 1 311 321 10.1016/0378-3812(93)87156-U 2-s2.0-0027544528 (Pubitemid 23637728)
18. Keck C. M., Müller R. H., Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. European Journal of Pharmaceutics and Biopharmaceutics 2006 62 1 3 16 10.1016/j.ejpb.2005.05.009 2-s2.0-28444461830 (Pubitemid 41736019)
19. Schultz S., Wagner G., Urban K., Ulrich J., High-pressure homogenization as a process for emulsion formation. Chemical Engineering & Technology 2004 27 4 361 368 10.1002/ceat.200406111 2-s2.0-2342619540 (Pubitemid 38587204)
20. Pääkko M., Ankerfors M., Kosonen H., Nykänen A., Ahola S., Österberg M., Ruokolainen J., Laine J., Larsson P. T., Ikkala O., Lindström T., Enzymatic hydrolysis combined with mechanical shearing and high-pressure homogenization for nanoscale cellulose fibrils and strong gels. Biomacromolecules 2007 8 6 1934 1941 10.1021/bm061215p 2-s2.0-34347351398 (Pubitemid 47009973)
21. Zhao X., Song K., Wang S., Zu Y., Li N., Yu X., Micronization of the pharmaceutically active agent genipin by an antisolvent precipitation process. Chemical Engineering & Technology 2013 36 1 33 42 10.1002/ceat.201200036 2-s2.0-84871648962
22. Zhang Y., Meng F. C., Cui Y. L., Song Y. F., Enhancing effect of hydroxypropyl- β -cyclodextrin on the intestinal absorption process of genipin. Journal of Agricultural and Food Chemistry 2011 59 20 10919 10926 10.1021/jf202712y 2-s2.0-80055021869
23. Debenedetti P. G., Tom J. W., Kwauk X., Yeo S.-D., Rapid expansion of supercritical solutions (RESS): fundamentals and applications. Pharmaceutical Research 1993 10 3 362 368 10.1023/A:1018980020506 2-s2.0-0027409962 (Pubitemid 23080599)
24. Zu Y., Meng L., Zhao X., Ge Y., Yu X., Zhang Y., Deng Y., Preparation of 10-hydroxycamptothecin-loaded glycyrrhizic acid-conjugated bovine serum albumin nanoparticles for hepatocellular carcinoma-targeted drug delivery. International Journal of Nanomedicine 2013 8 1207 1222 10.2147/IJN.S40493 2-s2.0-84875673833
25. Thakur G., Mitra A., Basak A., Rousseau D., Pal K., Characterization of oil-in-water gelatin emulsion gels: effect of homogenization time. Proceedings of the IEEE International Conference on Systems in Medicine and Biology (ICSMB '10) December 2010 Kharagpur, India 305 308 10.1109/ICSMB.2010.5735392 2-s2.0-79955676915
26. Tiyaboonchai W., Tungpradit W., Plianbangchang P., Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. International Journal of Pharmaceutics 2007 337 1-2 299 306 10.1016/j.ijpharm.2006.12.043 2-s2.0-34248549039 (Pubitemid 46756048)
27. Majerik V., Charbit G., Badens E., Horváth G., Szokonya L., Bosc N., Teillaud E., Bioavailability enhancement of an active substance by supercritical antisolvent precipitation. Journal of Supercritical Fluids 2007 40 1 101 110 10.1016/j.supflu.2006.03.027 2-s2.0-33845484838 (Pubitemid 44914177)
28. Lust A., Laidmäe I., Palo M., Meos A., Aaltonen J., Veski P., Heinämäki J., Kogermann K., Solid-state dependent dissolution and oral bioavailability of piroxicam in rats. European Journal of Pharmaceutical Sciences 2012 48 1-2 47 54
29. Hu J., Ng W. K., Dong Y., Shen S., Tan R. B. H., Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. International Journal of Pharmaceutics 2011 404 1-2 198 204 10.1016/j.ijpharm.2010.10.055 2-s2.0-78650679657
30. 2-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin. International Journal of Pharmaceutics 2013 454 1 278 284 10.1016/j.ijpharm.2013.06.051
31. Mallis L. M., Sarkahian A. B., Harris H. A., Zhang M. Y., McConnell O. J., Determination of rat oral bioavailability of soy-derived phytoestrogens using an automated on-column extraction procedure and electrospray tandem mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 2003 796 1 71 86 10.1016/j.jchromb.2003.08.003 2-s2.0-1542398964 (Pubitemid 38352711)
32. Yang K.-Y., Lin L.-C., Tseng T.-Y., Wang S.-C., Tsai T.-H., Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. Journal of Chromatography B 2007 853 1-2 183 189 10.1016/j.jchromb. 2007.03.010 2-s2.0-34249977666 (Pubitemid 46891353)
33. Cao X., Gibbs S. T., Fang L., Miller H. A., Landowski C. P., Shin H., Lennernas H., Zhong Y., Amidon G. L., Yu L. X., Sun D., Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharmaceutical Research 2006 23 8 1675 1686 10.1007/s11095-006-9041-2 2-s2.0-33746903600 (Pubitemid 44200529)
34. Carter C., Fisher T. C., Hamai H., Johnson C. S., Meiselman H. J., Nash G. B., Stuart J., Haemorheological effects of a nonionic copolymer surfactant (Poloxamer 188). Clinical Hemorheology and Microcirculation 1992 12 1 109 120 2-s2.0-0026517371
35. Constantinides P. P., Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects. Pharmaceutical Research 1995 12 11 1561 1572 10.1023/A:1016268311867 2-s2.0-0029562489 (Pubitemid 26005509)
36. Floury J., Desrumaux A., Lardières J., Effect of high-pressure homogenization on droplet size distributions and rheological properties of model oil-in-water emulsions. Innovative Food Science & Emerging Technologies 2000 1 2 127 134 10.1016/S1466-8564(00)00012-6 2-s2.0-0034196519
37. Blagden N., de Matas M., Gavan P. T., York P., Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates. Advanced Drug Delivery Reviews 2007 59 7 617 630 10.1016/j.addr.2007.05.011 2-s2.0-34548023425 (Pubitemid 47285407)
38. Dokoumetzidis A., Papadopoulou V., Macheras P., Analysis of dissolution data using modified versions of Noyes-Whitney equation and the Weibull function. Pharmaceutical Research 2006 23 2 256 261 10.1007/s11095-006-9093-3 2-s2.0-32544450657